Skip to main content
. 2017 Jul 31;8(38):64294–64302. doi: 10.18632/oncotarget.19729

Figure 4. UCP2, miR-30e and H-E staining change after over expression.

Figure 4

(A) Significantly increased miR-30e level in rat at hepatitis stage after miR-30e over expression. (B) Significantly increased UCP2 level after UCP2 over expression but significantly decreased UCP2 level after miR-30e over expression. (C) Respectively increased and decreased inflammatory cell infiltration in UCP2 and miR -30e over expression. *, p<0.05, compared with hepatitis + NC; *, p<0.01, compared with hepatitis + NC.